Brimonidine and Timolol and Moxetumomab Pasudotox-tdfk
Determining the interaction of Brimonidine and Timolol and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine / timolol ophthalmic
Brand name: Combigan
Synonyms: Brimonidine and timolol ophthalmic
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine and Timolol-Moxetumomab pasudotox-tdfk Intravenous
- Brimonidine and Timolol-Moxifloxacin
- Brimonidine and Timolol-Moxifloxacin (Systemic)
- Brimonidine and Timolol-Moxifloxacin Hydrochloride
- Brimonidine and Timolol-Moxifloxacin Injection
- Brimonidine and Timolol-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Brimonidine and timolol ophthalmic
- Moxetumomab Pasudotox-tdfk-Brimonidine ophthalmic
- Moxetumomab Pasudotox-tdfk-Brimonidine Tartrate eent
- Moxetumomab Pasudotox-tdfk-Brimonidine Tartrate topical
- Moxetumomab Pasudotox-tdfk-Brimonidine topical
- Moxetumomab Pasudotox-tdfk-Brimonidine Topical application